1. Home
  2. SLP vs PUBM Comparison

SLP vs PUBM Comparison

Compare SLP & PUBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLP
  • PUBM
  • Stock Information
  • Founded
  • SLP 1996
  • PUBM 2006
  • Country
  • SLP United States
  • PUBM United States
  • Employees
  • SLP N/A
  • PUBM N/A
  • Industry
  • SLP EDP Services
  • PUBM Computer Software: Prepackaged Software
  • Sector
  • SLP Technology
  • PUBM Technology
  • Exchange
  • SLP Nasdaq
  • PUBM Nasdaq
  • Market Cap
  • SLP 675.9M
  • PUBM 576.6M
  • IPO Year
  • SLP 1997
  • PUBM 2020
  • Fundamental
  • Price
  • SLP $18.32
  • PUBM $12.43
  • Analyst Decision
  • SLP Buy
  • PUBM Buy
  • Analyst Count
  • SLP 7
  • PUBM 11
  • Target Price
  • SLP $40.40
  • PUBM $22.60
  • AVG Volume (30 Days)
  • SLP 571.2K
  • PUBM 593.7K
  • Earning Date
  • SLP 07-14-2025
  • PUBM 08-07-2025
  • Dividend Yield
  • SLP 0.32%
  • PUBM N/A
  • EPS Growth
  • SLP N/A
  • PUBM N/A
  • EPS
  • SLP 0.36
  • PUBM 0.10
  • Revenue
  • SLP $78,564,000.00
  • PUBM $288,380,000.00
  • Revenue This Year
  • SLP $27.66
  • PUBM $2.70
  • Revenue Next Year
  • SLP $6.75
  • PUBM $10.37
  • P/E Ratio
  • SLP $51.73
  • PUBM $126.26
  • Revenue Growth
  • SLP 21.49
  • PUBM 3.62
  • 52 Week Low
  • SLP $16.72
  • PUBM $7.46
  • 52 Week High
  • SLP $49.05
  • PUBM $22.99
  • Technical
  • Relative Strength Index (RSI)
  • SLP 29.54
  • PUBM 65.14
  • Support Level
  • SLP $16.78
  • PUBM $11.09
  • Resistance Level
  • SLP $17.70
  • PUBM $12.97
  • Average True Range (ATR)
  • SLP 1.15
  • PUBM 0.41
  • MACD
  • SLP -0.00
  • PUBM 0.08
  • Stochastic Oscillator
  • SLP 14.61
  • PUBM 74.78

About SLP Simulations Plus Inc.

Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

About PUBM PubMatic Inc.

PubMatic Inc is a supply-side platform provider in the digital advertising technology market. These platforms help publishers, which supply digital ad inventory, manage their inventory, selling a high percentage of their inventory (increase the ad fill rate) and maximizing revenue per ad sold (optimize yield). The company generates revenue mainly by taking a piece of the ad sales that it enables. Buyers on the platform include intermediary buyers, such as demand-side platforms, or advertisers and ad agencies directly. Geographically, the company generates the majority of its revenue from the United States, followed by EMEA and APAC.

Share on Social Networks: